Company Filing History:
3 out of 33 
2 out of 97 
2 out of 2 
Years Active: 2018-2025
Title: Alexander Astrakhan: Innovator in Genome Editing and Immune Cell Signaling
Introduction
Alexander Astrakhan is a prominent inventor based in Seattle, WA, known for his significant contributions to the fields of genome editing and immune cell signaling. With a total of seven patents to his name, he has made remarkable advancements that have the potential to transform medical treatments.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Multipartite signaling proteins and uses thereof." This patent focuses on compositions and methods for utilizing cells with chemically-induced fusion protein complexes to control immune cell signal initiation and downstream responses for disease treatment. The invention includes fusion polypeptides that comprise various essential components, such as secretion signals and multimerization domains. Another notable patent is "Donor repair templates multiplex genome editing," which provides improved compositions and methods for multiplex genome editing. This innovation aims to create genome-edited cells that can prevent or treat various diseases, including hemoglobinopathies, cancers, and autoimmune diseases.
Career Highlights
Throughout his career, Alexander has worked with leading companies in the biotechnology sector, including Bluebird Bio, Inc. and Cellectis. His work has been instrumental in advancing the understanding and application of genetic engineering techniques.
Collaborations
Alexander has collaborated with notable professionals in his field, including Jordan Jarjour and Michael Certo. These partnerships have contributed to the development of innovative solutions in biotechnology.
Conclusion
Alexander Astrakhan's work exemplifies the impact of innovation in the medical field, particularly in genome editing and immune response modulation. His patents and collaborations continue to pave the way for future advancements in healthcare.